Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.

Celi FS, Zemskova M, Linderman JD, Smith S, Drinkard B, Sachdev V, Skarulis MC, Kozlosky M, Csako G, Costello R, Pucino F.

J Clin Endocrinol Metab. 2011 Nov;96(11):3466-74. doi: 10.1210/jc.2011-1329. Epub 2011 Aug 24.

2.

Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone.

Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, Galán JM, Barrios V, Sancho J.

Ann Intern Med. 2005 Mar 15;142(6):412-24.

PMID:
15767619
3.
4.

The dynamic pituitary response to escalating-dose TRH stimulation test in hypothyroid patients treated with liothyronine or levothyroxine replacement therapy.

Yavuz S, Linderman JD, Smith S, Zhao X, Pucino F, Celi FS.

J Clin Endocrinol Metab. 2013 May;98(5):E862-6. doi: 10.1210/jc.2012-4196. Epub 2013 Apr 12.

5.

The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients.

Celi FS, Zemskova M, Linderman JD, Babar NI, Skarulis MC, Csako G, Wesley R, Costello R, Penzak SR, Pucino F.

Clin Endocrinol (Oxf). 2010 May;72(5):709-15. doi: 10.1111/j.1365-2265.2009.03700.x.

6.
7.

Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study.

Kaminski J, Miasaki FY, Paz-Filho G, Graf H, Carvalho GA.

Arch Endocrinol Metab. 2016 Nov-Dec;60(6):562-572. doi: 10.1590/2359-3997000000192. Epub 2016 Aug 25.

8.

Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine.

Slawik M, Klawitter B, Meiser E, Schories M, Zwermann O, Borm K, Peper M, Lubrich B, Hug MJ, Nauck M, Olschewski M, Beuschlein F, Reincke M.

J Clin Endocrinol Metab. 2007 Nov;92(11):4115-22. Epub 2007 Aug 21.

PMID:
17711927
9.

Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study.

Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK.

J Clin Endocrinol Metab. 2013 May;98(5):1982-90. doi: 10.1210/jc.2012-4107. Epub 2013 Mar 28.

PMID:
23539727
10.

TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).

Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Müller B.

J Clin Endocrinol Metab. 2001 Oct;86(10):4860-6.

PMID:
11600554
11.

Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.

Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG, Endert E, van Weert HC, Wiersinga WM.

J Clin Endocrinol Metab. 2005 May;90(5):2666-74. Epub 2005 Feb 10.

PMID:
15705921
12.

Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism.

Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, Dhaliwal SS, Chew GT, Bhagat MC, Cussons AJ.

J Clin Endocrinol Metab. 2003 Oct;88(10):4543-50.

PMID:
14557419
13.

The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial.

Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU.

J Clin Endocrinol Metab. 2007 May;92(5):1715-23. Epub 2007 Feb 13.

PMID:
17299073
15.

Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial.

Walsh JP, Ward LC, Burke V, Bhagat CI, Shiels L, Henley D, Gillett MJ, Gilbert R, Tanner M, Stuckey BG.

J Clin Endocrinol Metab. 2006 Jul;91(7):2624-30. Epub 2006 May 2.

PMID:
16670161
16.

Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment.

Laurberg P, Andersen S, Bülow Pedersen I, Carlé A.

Drugs Aging. 2005;22(1):23-38. Review.

PMID:
15663347
17.

Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.

Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sänger E, Engel G, Hamm AO, Nauck M, Meng W.

Clin Endocrinol (Oxf). 2004 Jun;60(6):750-7.

PMID:
15163340
18.

L-T3 preparation for whole-body scintigraphy: a randomized-controlled trial.

Leboeuf R, Perron P, Carpentier AC, Verreault J, Langlois MF.

Clin Endocrinol (Oxf). 2007 Dec;67(6):839-44. Epub 2007 Jul 20.

PMID:
17645577
19.

Treatment of hypothyroidism with levothyroxine or a combination of levothyroxine plus L-triiodothyronine.

Escobar-Morreale HF, Botella-Carretero JI, Morreale de Escobar G.

Best Pract Res Clin Endocrinol Metab. 2015 Jan;29(1):57-75. doi: 10.1016/j.beem.2014.10.004. Epub 2014 Oct 25. Review.

PMID:
25617173
20.

Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial.

Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JG, Berghout A.

Arch Intern Med. 2010 Dec 13;170(22):1996-2003. doi: 10.1001/archinternmed.2010.436.

PMID:
21149757

Supplemental Content

Support Center